LearnOn Podcast: The Science Show By Kids, For Everyone! – Détails, épisodes et analyse

Throughout this season in the podcast, we have explored the unique role of cutting-edge technology in driving innovation for medicine. But what about the other way around? It turns out that the unique makeup of the healthcare system is crucial in the context of leading changes in digital health. Today, we're hearing from Noelle Eder, CIO at The Cigna Group, for her insights through a career of over 30 years. Tune in to hear about the verticalization of American healthcare, how the fragmentation of this space affects the demand for innovation in medical technology, and the importance of empathy in leadership.
Noelle Eder is the Executive Vice President and Global Chief Information Officer (CIO) at The Cigna Group. Prior to this role, she served as the Chief Information and Digital Officer at Hilton Worldwide Holdings, the Chief Card Customer Experience Officer for Capital One Financial Corporation, as well as other technology leadership roles at Intuit and TeKnowledge.

You've probably heard about gene editing to create hybrid species or designer babies. But what about its purpose to aid the wellbeing of humanity? Today, we're joined by Ian Karp on behalf of Intellia Therapeutics, a biotechnology company employing CRISPR-based gene editing to develop curative therapeutics for cancer and autoimmune disease. Tune in to hear his thoughts on recent clinical trial updates, how to effectively communicate the purpose of these therapies with the public, and what it's like to be at the forefront of medical innovation when it comes to gene editing.
Check out the work that Intellia is doing: www.intelliatx.com/
Ian Karp is a Senior Vice President at Intellia Therapeutics. He has over 25 years of expertise in the biopharmaceutical industry for investor relations, corporate communications, business development, and product commercialization.

If something like the COVID-19 pandemic ever happened again, how would we deal with it? Would it be any different from last time? Through our experiences from 2020 to now, it's important to remember how crucial vaccine development and preventative research efforts are in matters of public health. Today, we're joined by Dr. Barney Graham, who has made major contributions to vaccines for HIV/AIDS, Zika, RSV, and ultimately SARS-CoV-2. Tune in to hear Dr. Graham's firsthand experiences with discovering virus spike proteins, working on various teams to develop vaccines for different epidemics, and advocating for global health policy reform.
Dr. Barney Graham is the former deputy director and one of the founding members of the Vaccine Research Center, which is part of the National Institutes of Health (NIH). He was elected a member of the National Academy of Sciences in 2022 and currently serves as the director of the David Satcher Global Health Equity Institute at the Morehouse School of Medicine.

Some of the biggest scientific discoveries and biotechnology companies today were born out of skepticism. But what is it actually like to have participated in building this work from the group up? Today, we're hearing a first-hand perspective in this from Dr. Robert Langer, billionaire cofounder of Moderna and widely renowned biotechnologist. Join us in a riveting discussion about how the ups and downs of his career taught him to advocate for himself through research, how his lab is collaborating with The Gates Foundation to create more efficient treatments for developing countries with novel drug delivery systems, and the importance of having a creative mindset to find solutions in unusual places.

Dr. Robert Langer is currently an Institute Professor at MIT and a faculty member of the Harvard–MIT Program in Health Sciences and Technology. Having authored over 1,500 scientific papers, he is the most cited engineer in history and one of the 10 most cited individuals in any field. Dr. Langer has participated in founding 40+ biotechnology companies including Moderna and holds over 1,500 granted or pending patents.

Many of us have early memories of visits to the pediatrician, which are often underscored by fear of the dreaded needle. Being poked and prodded is never fun regardless of your age, but it's especially important to consider that a lot of this discomfort is unnecessary. And, traumatizing experiences in young patients can foster distrust for healthcare workers during their formative years. Today, we're chatting with Dr. Stefan Friedrichsdorf about palliative care, advocating for pain management in pediatrics, and how taking a bit of extra time for a simple, evidence-backed procedure to reduce anxiety during vaccinations can help kids develop positive associations with the healthcare system through adulthood.

Dr. Stefan Friedrichsdorf is a pediatric pain and palliative medicine specialist. Through his roles as a professor of pediatrics at UCSF and the medical director of the Stad Center for Pediatric Pain, Palliative and Integrative Medicine, he is helping to make pain management for kids a #1 priority through their care.

From a privileged perspective, it can be easy to consider good mental health as an additional benefit on top of the precursor of physical health. However, it turns out that we need to reframe this mindset, especially in the context of social communities and developing countries. Today, we're chatting with Sean Mayberry about StrongMinds, a global nonprofit treating hundreds of thousands of people each year, mostly in Africa, with depression. Tune in to hear about the surprisingly controversial label of mental health, the sustainability of group therapy approaches for depression, and how mental health care targeted at caregivers improves many other factors in the household.

Sean Mayberry is the CEO of StrongMinds, a TEDx speaker, and a renowned humanitarian addressing health outcomes in poverty-stricken communities. Prior to founding this organization, he worked as a diplomat and social marketer implementing programs for malaria and HIV/AIDS prevention in Africa.
See the work at StrongMinds: strongminds.org/

From asbestos to PFAS to microplastics, nowadays it seems like harmful chemicals are present everywhere we turn. Though there are certainly many hazardous chemicals in our environment, there's also a large amount of misinformation about how these findings are communicated and in what capacity they become toxic. To clear up the air, we're joined today by Dr. Michal Freedhoff, head of the Office of Chemical Safety and Pollution Prevention (OCSSP). Tune in to hear her unique perspective on how safety regulations became more rigorous since 2016 under the revised Toxic Substances Control Act (TSCA), how we still see impacts of historical ignorance around chemical safety in today's chemical regulations, and the dire need to prevent science from turning into a weapon of uncertainty through accusatory claims against scientists.
Michal Freedhoff is the Assistant Administrator for the Office of Chemical Safety and Pollution Prevention (OCSPP). She has a PhD in physical chemistry from the University of Rochester and has over 20 years of government experience, including serving on scientific research and development committees of the United States Senate and House of Representatives.

Wouldn't it be amazing to have a long weekend every week and still get paid full time? It turns out that this isn't just a magical fantasy, but rather a reality for employees at hundreds of companies across the globe. And not only is it fun to have Fridays off, but it's also an evidence-proven method of reducing burnout, increasing revenue with higher overall productivity, and retaining existing employees as well as attracting new talent. Today, we're interviewing Dale Whelehan, who is spearheading the initiative to convince skeptics and create a million new years of free time through 4 Day Week Global. Join us to hear important insights about the science of tunnel vision resulting from burnout, the 100-80-100 rule of work output, and making this a widespread reality through a fundamental culture shift around work.
Dale Whelehan is the CEO of 4 Day Week Global and has a PhD in Behavioral Science from Trinity College Dublin. He is on the 2024 Forbes 30 Under 30 list, a member of the Forbes Business Council, and an Advisory Council Member of the Harvard Business Review.
See the 4 Day Week Global website: www.4dayweek.com/

As we continue to build our knowledge about gender differences healthcare, an important part of the scene is femtech, which refers to a wide range of solutions applying technology to serve women's health. But what does femtech truly mean in its execution, and how does it affect concerns about health equity today? To tackle these questions, we're joined by Amy Keenan on behalf of FemHealth Insights, an organization empowering stakeholders in women's health through data and community building. Tune in to hear all about the underrepresentation of female patients in clinical trials and the future of joint advocacy efforts in shaping more equitable healthcare.

Amy Keenan is a leader in women's health as a 2024 fellow for FemHealth Insights. She is leading the campaign for Dr. Brittany Baretto, Chief Information Officer of FemHealth Insights, as she launches the book Unlocking Women's Health: FemTech and the Quest for Gender Equity.

Tune into the FemTech Focus podcast: www.femtechfocus.com/
Check out Dr. Brittany Baretto's new book: www.amazon.com/Unlocking-Womens-Health-FemTech-Gender/dp/1961347911